ImmuPharma plc (FRA:25I)
0.0800
+0.0225 (39.13%)
At close: Nov 27, 2025
ImmuPharma Market Cap
ImmuPharma has a market cap or net worth of €36.6 million as of December 1, 2025. Its market cap has increased by 351.86% in one year.
Market Cap
36.60M
Enterprise Value
36.15M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.08
Market Cap Chart
Since February 22, 2006, ImmuPharma's market cap has decreased from 52.96M to 36.60M, a decrease of -30.89%. That is a compound annual growth rate of -1.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 36.60M | 503.16% |
| Dec 31, 2024 | 6.07M | -24.15% |
| Dec 29, 2023 | 8.00M | 15.67% |
| Dec 30, 2022 | 6.92M | -64.83% |
| Dec 31, 2021 | 19.66M | -47.26% |
| Dec 31, 2020 | 37.28M | 17.98% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |